STOCKHOLM – Sweden is pausing the use of the AstraZeneca COVID-19 vaccine as a precautionary measure amid concerns about reports of blood clots in some recipients in Europe.

“The decision is a precautionary measure,” Sweden’s chief epidemiologist, Anders Tegnell, said in a statement.

The move by the Swedish Public Health Agency was to remain in effect until an investigation by the European Medicines Agency into suspected side effects is complete.

TOP STORIES Sarah Silverman: ‘I don’t want to be associated’ with Democratic Party anymore ‘Wow this is on network TV’: Raunchy Grammy Awards sparks outrage, sheds viewers Trump’s judicial appointees give Republicans hope to revoke Biden’s flood of executive orders

A growing number of European countries – including Germany, France, Italy and Spain – have suspended use of AstraZeneca’s vaccine, though the company and international regulators say there is no evidence the shot is to blame for the blood clots.

Sweden has stood out for its comparatively mild response to the pandemic. The country avoided lockdowns and relied instead on citizens’ sense of civic duty to control infections. As of Tuesday, more than 13,140 people had died of COVID-19 in the Scandinavian country, far more per capita than in Sweden’s neighbors but fewer than in other European countries that did implement strict lockdowns or curfews.



– Why countries are halting the AstraZeneca vaccine, though there is no evidence the shot is responsible for reported blood clots

– Thailand’s PM receives AstraZeneca vaccine as much of Asia shrugs off reported blood clots in Europe

– China adds 4th vaccine to its arsenal, with final round testing underway in Pakistan, Indonesia and Uzbekistan

– Extent of COVID-19 vaccine waste due to mishandling, poor recording keeping and other reasons, remains largely unknown

– Follow AP’s pandemic coverage at, and



UNITED NATIONS – China’s U.N. ambassador says China is donating 300,000 doses of COVID-19 vaccines to U.N. peacekeepers, with priority given to those serving in Africa.

Ambassador Zhang Jun sent a letter to U.N. Secretary-General Antonio Guterres informing him of the donation, China’s U.N. Mission said Monday. It follows the announcement by China’s Foreign Minister Wang Yi of Beijing’s intention to donate vaccines at a U.N. Security Council meeting on Feb. 17.

The mission said “China attaches great importance to the safety and security of peacekeepers” and the donation “is a further step to make China’s vaccines a global public good, and also a demonstration of China’s firm and continuous support to the U.N. and multilateralism.”

Last month, the U.N. thanked India for offering 200,000 COVID-19 vaccine doses for U.N. peacekeepers.

The U.N. currently has a dozen peacekeeping operations, half in Africa with a total of about 100,000 peacekeepers.

There was no immediate word on what the U.N. plans to do with the two offers.


OSAKA, Japan – Takeda Pharmaceutical Co. Ltd. is the latest drugmaker to offer help with production of a rival’s COVID-19 vaccine as their industry works to churn out billions of vaccine doses.

Takeda, one of Japan’s top vaccine makers, said Monday it’s reached a deal to have a German contract drug manufacturer temporarily use capacity at its factories that had been reserved for Takeda to instead produce Johnson & Johnson’s single-dose COVID-19 shot.

Germany’s IDT Biologika Gmbh previously had saved capacity to make Takeda’s experimental dengue vaccine, now in final testing before regulatory reviews, ahead of the planned launch of the dengue shot.

Under the three-company deal, starting this month IDT will manufacture the Johnson & Johnson vaccine for three months, then resume manufacture of the dengue vaccine candidate.

Takeda previously said it will manufacture more than 250 million doses of a COVID-19 vaccine developed by Novavax that’s likely to be approved in a few months, with that supply meant for Japan.

Meanwhile, Takeda has been testing its existing products to see if they are effective against the coronavirus. Takeda also plans to distribute 50 million doses of Moderna’s vaccine in Japan and has multiple partnerships with other companies to try to develop other treatments and vaccines to fight the pandemic.


ATLANTA – Georgia threw open the doors for COVID-19 vaccination to a majority of adults Monday, as the state seeks to improve its worst-in-the-nation share of the population that has been inoculated against the respiratory illness.

Monday was the first day that people aged 55 to 64 could get shots, as well as people with serious health conditions and those who are overweight and obese.

Officials with Gov. Brian Kemp’s office say that, overall, another 3.3 million people are eligible, meaning more than 5 million Georgians overall can now seek vaccination.

The state will open five new mass vaccination sites on Wednesday and the federal government will take over a site in Atlanta.

Georgia has only given 20.8% of its adult population at least one dose, the worst in the nation, according to the U.S. Centers for Disease Control and Prevention. The same data show Georgia has administered the second-lowest share of doses delivered among states, with more than one-third of doses still awaiting injection.


LISBON, Portugal – Portugal is following other European Union countries and temporarily halting use of the AstraZeneca coronavirus vaccine while experts review its safety.

The General Director for Health, Graça Freitas, told a Monday evening news conference that Portugal has so far seen none of the cases of dangerous blood clots in some recipients recorded elsewhere in Europe.

Officials said they hoped a scientific review of the jab can be completed by the end of the week.

Freitas urged people who have had the AstraZeneca vaccine to remain calm.

Portugal is postponing the mass vaccination of educational workers scheduled for next weekend because of the AstraZeneca suspension.


NEW YORK – Two new studies add evidence that a virus variant first detected in Britain is more deadly than the previous dominant form.

Other research had already demonstrated the strain is more transmissible, but a new paper published Monday in the journal Nature suggests the U.K. variant may also be associated with an increased risk of death.

Comparing cases in more than 1 million people infected in England, researchers from the London School of Hygiene and Tropical Medicine estimated the risk of death was about 55% higher for those with the new variant versus the previous one.

For men in their 50s or 60s, that meant the risk of death went from 0.06% to 0.09% with the new strain.

In a University of Exeter study published in the British journal BMJ last week, researchers followed about 100,000 positive COVID-19 cases, matching pairs of participants on age, sex and other factors. They also found those with the U.K. variant were at higher risk of death during the study.

The variant has been found in all but a few states in the U.S. and is expected to become the dominant strain later this spring.

Manage Newsletters

Copyright © 2021 The Washington Times, LLC.


Similar articles:

  1. Doctors baffled as countries suspend use of AstraZeneca vaccine over blood clot fears []
  2. Thai PM gets AstraZeneca jab as country resumes rollout despite concerns []
  3. WHO experts to meet on AstraZeneca shot as virus cases surge []
  4. ‘The damage is done’: Europe’s caution over AstraZeneca vaccine could have far-reaching consequences []
  5. Germany postpones vaccination summit over AstraZeneca furor []
  6. Venezuela won’t authorise AztraZeneca vaccine due to safety fears []
  7. EU humiliation: Three of the top four European countries for Covid vaccines are not in EU []
  8. Countries halting AstraZeneca vaccine []
  9. Sweden, Venezuela Are Latest Countries To Question AstraZeneca Vaccine []
  10. Vaccination of teachers with AstraZeneca doses has started []
  11. Sweden, Latvia suspend use of AstraZeneca’s COVID-19 vaccine []
  12. Reassurance Given Over AstraZeneca Jab []
  13. COVID-19: WHO and European Medicines Agency to meet on AstraZeneca vaccine []
  14. German COVID-19 cases are growing exponentially again -RKI []
  15. WHO And EU Experts To Discuss AstraZeneca Vaccine After Several Countries Suspend Its Use []
  16. Spain temporarily suspends use of AstraZeneca vaccine []
  17. Astra Zeneca’s vaccine is stopped in Sweden Lyssna från tidpunkt: []
  18. WHO experts to meet over AztraZeneca vaccine concerns []
  19. The Latest: Sweden pauses use of AstraZeneca vaccine []
  20. Pavluts hopes that vaccination with AstraZeneca vaccine could resume already this week []
  21. Government: ‘No concerns’ about AstraZeneca vaccine []
  22. EU drug regulator investigating AstraZeneca vaccine []
  23. The Latest: Sweden pauses use of AstraZeneca vaccine []
  24. Thai PM Gets First Shot of AstraZeneca Vaccine []
  25. Should you be concerned about blood clots, bleeding and the AZ-vaccine? []
  26. Venezuela will not authorise AstraZeneca COVID-19 vaccine due to ‘effects on patients’, VP says []

Leave a Reply

Your email address will not be published. Required fields are marked *